Bought
Maintained
Sold
Other funds holding DXR
TRCT
GSC
BIM
UBS's DXR Position: Q3 2014 in Review
UBS increased its Daxor (DXR) stake by 17% in Q3 2014, buying an estimated $892 and bringing the position to 905 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #9274.
UBS first reported a position in DXR in Q2 2013 and has held it in 6 quarters since. The position peaked at $10K in Q4 2013. 10 funds tracked by Wall St. Rank hold DXR as of Q3 2014.
- UBS held 905 shares of Daxor worth $6K as of Q3 2014.
- UBS bought 129 Daxor shares in Q3 2014, an estimated $892.
- Daxor made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9274 holding.
- UBS first reported a position in Daxor in Q2 2013 and has held it in 6 quarters since.
- UBS's Daxor position peaked at $10K in Q4 2013.
- 10 funds tracked by Wall St. Rank held Daxor as of Q3 2014.
Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.